Tirofiban (Aggrastat) Table    body {font-family: 'Open Sans', sans-serif;}

### Tirofiban (Aggrastat) and Neuraxial Block

table.tableizer-table { font-size: 12px; border: 1px solid #CCC; font-family: Arial, Helvetica, sans-serif; } .tableizer-table td { padding: 4px; margin: 3px; border: 1px solid #CCC; } .tableizer-table th { background-color: #104E8B; color: #FFF; font-weight: bold; }

| Minimal Time between  
last dose and neuraxial procedure | Can it be given with  
epidural catheter in place? | Restart after  
neuraxial procedure and/or  
catheter insertion | Restart after catheter removal |
| --- | --- | --- | --- |
| Avoid until platelet function has returned  
to normal.  
  
GP IIb/IIIa antagonists are normally  
held 4 weeks prior to elective surgery. | NO | Avoid  
  
DO not restart if indwelling  
catheter is in place. | Avoid |

  
**Deep plexus and peripheral blocks:** Same recommendations as neuraxial.**Superficial peripheral blocks:** Based on vascularity, site compressibility and available management if bleeding occurred.  
  
**Labs**  
Platelet function assayAlways refer to the latest ASRA (American Society of Regional Anesthesia and Pain) Recommendations  
https://www.asra.com/advisory-guidelines  
  
ASRA Assistance:  
Toll free in US: 855-795-ASRA (2772)  
412-471-2718  
asraassistant@asra.com